معلومات عن هذه الحلقة
Did you know that tapinarof was discovered on a nematode and has a unique agonist mechanism of action with anti-inflammatory and skin barrier benefit in both psoriasis and atopic dermatitis? Listen in as Skin Sync hosts, Buchi Neita and Shanna Miranti, take us through the science and clinical trial data.
الإنجليزية
الولايات المتحدة
النص 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
البحث في الحلقات الماضية
البحث في الحلقات السابقة من SkinSync.
حلقات أخرى في هذا البودكاست
Rounding out our hair loss mini series, this episode focuses on scarring alopecia-from diagnosis, to treatment, to patient counseling strategies.
How do you approach shared decision making with your patients? Tune in to hear how our podcasts hosts ensure patients have ownership in their own dermatological care and are comfortable with the treatment path they discuss.
Pediatric patients with atopic dermatitis often face disruptions in sleep, growth and development, and behavioral challenges that can greatly impact their quality of life. The advancement of systemic biologic therapy in children with atopic dermatitis is shown to improve outcomes across the board f…
Psoriatic arthritis is estimated to affect more than a third of patients with plaque psoriasis. Early recognition and treatment is critical in preventing permanent joint destruction. We sat down with psoriasis expert and Chief of Dermatology at UCLA, Dr. April Armstrong, to discuss how she screens …
إخلاء المسؤولية: البودكاست والأعمال الفنية المضمنة في هذه الصفحة مأخوذة من Elevate-Derm Alliance، وهي مملوكة لمالكها وليست تابعة لشركة Listen Notes, Inc أو معتمدة منها.
تعديل
شكراً على مساعدتنا في الحفاظ على قاعدة بيانات البودكاست مُحدَّثة.
